Milestone Pharmaceuticals...

NASDAQ: MIST · Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.68
-0.88%
After-hours: Aug 15, 2025, 06:50 PM EDT

Milestone Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 1M 5M 15M
Cost of Revenue
n/a n/a 480K n/a
Gross Profit
n/a 1M 4.52M 15M
Operating Income
-42.1M -61.1M -59.64M -43.07M
Interest Income
4.16M 3.97M 1.25M 220K
Pretax Income
-41.78M -59.69M -58.39M -42.85M
Net Income
-41.52M -59.69M -57.13M -42.63M
Selling & General & Admin
27.1M 31.05M 24.81M 19.4M
Research & Development
14.62M 31.05M 39.83M 38.67M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
31.1M 62.1M 64.64M 58.07M
Interest Expense
-3.58M 2.55M n/a n/a
Selling & Marketing Expenses
10.36M 15.11M 9.1M 7M
Cost & Expenses
n/a 62.1M 64.64M 58.07M
Income Tax Expense
-259K n/a -1.25M -220K
Shares Outstanding (Basic)
62.21M 42.96M 42.45M 41.83M
Shares Outstanding (Diluted)
62.21M 42.96M 42.45M 41.83M
EPS (Basic)
-0.67 -1.39 -1.35 -1.02
EPS (Diluted)
-0.67 -1.39 -1.35 -1.02
EBITDA
-42.1M -56.84M -58.36M -42.98M
EBIT
-38.2M -57.13M -58.84M -43.07M
Depreciation & Amortization
-3.9M 92K 480K 362K